ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Salidroside alleviates dexamethasone-induced inhibition of bone formation via transforming growth factor-beta/Smad2/3 signaling pathway

Xie, Baocheng; Zhou, Huan; Liu, Hongyu; Liao, Shiyi; Zhou, Chenhui; Xu, Daohua*广东医学院; 南方医科大学
Phytotherapy Research2023-5DOI: 10.1002/ptr.7711
1被引5阅读
引用收藏
分享

摘要

Glucocorticoid-induced osteoporosis is the third epidemic osteoporosis following postmenopausal and senileosteoporosis. According to one study, salidroside made ovariectomized rats' bones strong. Salidroside's potential for treating glucocorticoid-induced osteoporosis remains unproven. This study aimed to investigate the protective effect and mechanism of salidroside on dexamethasone-induced osteogenic differentiation and bone formation in MC3T3-E1 cells and zebrafish. The study proved that salindroside had no harmful impact on MC3T3E1 cells. Salidroside significantly relieved dexamethasone-induced inhibition of ALP (alkaline phosphatase) activity and mineralization in MC3T3-E1 cells, and promoted osteogenic differentiation of cells. Salidroside increased the expression of osteopontin (OPN), runt-related transcription factor 2 (Runx2), osterix (Osx), transforming growth factor-beta (TGF-beta) proteins and promoted the phosphorylation of Smad2/3 in MC3T3-E1 cells treated with dexamethasone. In addition, the effect of salidroside in relieving dexamethasone-induced inhibition of osteogenic differentiation in MC3T3-E1 cells can be blocked by TGF-beta receptor type I/II inhibitor (LY2109761). At the same time, we found that salidroside significantly alleviated the inhibition of dexamethasone-induced bone formation in zebrafish and promoted the mineralization of zebrafish skulls. LY2109761 reversed the protective impact of salidroside on dexamethasone-mediated bone impairment in zebrafish. These findings suggested that salidroside alleviated dexamethasone-induced inhibition of osteogenic differentiation and bone formation via TGF-beta /Smad2/3 signaling pathway.

学科与关键词

关键词
glucocorticoidosteoblast differentiationosteoporosissalidrosideTGF-betaSmad23 signaling pathway
相关
加载中…
  • Epimedin C Alleviates Glucocorticoid-Induced Suppression of Osteogenic Differentiation by Modulating PI3K/AKT/RUNX2 Signaling Pathway
    Xu, Yongxiang; Chen, Shichun; Huang, Linxuan; Han, Weichao; Shao, Yingying; Chen, Minyi; Zhang, Yusheng; He, Ruirong*; Xie, Baocheng*Frontiers in Pharmacology, 2022, 13: 894832.被引 4
  • Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
    Xie, Baocheng; Zeng, Zhanwei; Liao, Shiyi; Zhou, Chenhui; Wu, Longhuo*; Xu, Daohua*Frontiers in Pharmacology, 2021, 12: 739326.被引 23
  • Tanshinol Alleviates Microcirculation Disturbance and Impaired Bone Formation by Attenuating TXNIP Signaling in GIO Rats
    Lai, Wenxiu; Mo, Yulin; Wang, Dongtao; Zhong, Ying; Lu, Lujiao; Wang, Jiajia; Cui, Liao*; Liu, Yanzhi*; Yang, Yajun*Frontiers in Pharmacology, 2021, 12: 722175.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Phytotherapy Research
发表日期
2023-05
卷期
第 37 卷, 第 5 期
页码
1938-1950
DOI
10.1002/ptr.7711
语言
ENGLISH
成果收录
SCIE

作者

  • X

    Xie, Baocheng (第一作者)

    guangdong med univ · southern med univ

  • Z

    Zhou, Huan

    guangdong med univ · new

查看全部 6 位作者收起作者
  • L

    Liu, Hongyu

    guangdong med univ · new

  • L

    Liao, Shiyi

    guangdong med univ · new

  • Z

    Zhou, Chenhui

    guangdong med univ

  • X

    Xu, Daohua (通讯)

    guangdong med univ · new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417